
05/08/2025
How does the RelieVRx program change outcomes for high-impact chronic pain (HICP) patients who suffer with chronic lower back pain?
According to AppliedVR’s latest clinical study (n=1000+):
▪️Pain Intensity Reduction: Average 2.0 point reduction (clinically meaningful).
▪️Pain Interference Reduction: Average 2.3 point reduction.
▪️Sustained Improvements: Benefits lasting up to 24-months with HICP patients transitioning to low impact chronic pain (LICP) up to 12 months post treatment.
▪️Daily function gains: Better sleep, mood, stress and physical functioning.
▪️Safety profile: No serious adverse events reported.
RelieVRx isn’t short-term symptom management. It’s a durable, long-term, home based solution for some of the hardest to treat populations.
Learn more about the study and what it means: https://www.relievrx.com/news-and-media